CCMH
ARNA

Cornerstone Capital Management Holdings’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Cornerstone Capital Management Holdings’s Portfolio ARNA Stock Details ARNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		$734K Sell
21,642
-100
-0.5% -$2.85K 0.01% 953
2017
Q3 		$554K Sell
21,742
-5,300
-20% -$122K ﹤0.01% 1041
2017
Q2 		$455K Sell
27,042
-796
-3% -$10.9K ﹤0.01% 1051
2017
Q1 		$405K Buy
27,838
+20,748
+293% +$307K ﹤0.01% 1090
2016
Q4 		$100K Sell
7,090
-13,720
-66% -$213K ﹤0.01% 1243
2016
Q3 		$363K Buy
20,810
+960
+5% +$15.9K ﹤0.01% 1118
2016
Q2 		$339K Sell
19,850
-350
-2% -$6.26K ﹤0.01% 1107
2016
Q1 		$398K Sell
20,200
-26,854
-57% -$430K ﹤0.01% 1091
2015
Q4 		$894K Buy
47,054
+44,124
+1,506% +$900K 0.01% 919
2015
Q3 		$56K Sell
2,930
-37,610
-93% -$1.28M ﹤0.01% 1393
2015
Q2 		$1.88M Buy
40,540
+40,160
+10,568% +$1.74M 0.02% 733
2015
Q1 		$17K Buy
+380
New +$17.7K ﹤0.01% 1347
2014
Q3 		– Sell
-3,940
Closed -$230K – 1370
2014
Q2 		$230K Buy
3,940
+10
+0.3% +$630 ﹤0.01% 1094
2014
Q1 		$248K Buy
+3,930
New +$261K ﹤0.01% 1085

Other funds holding ARNA

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Cornerstone Capital Management Holdings's ARNA Position: Q4 2017 in Review

Cornerstone Capital Management Holdings reduced its Arena Pharmaceuticals Inc (ARNA) stake by 0.46% in Q4 2017, selling an estimated $2.85K and leaving 21,642 shares worth $734K. The position accounts for 0.01% of the portfolio, ranked #953.

Cornerstone Capital Management Holdings first reported a position in ARNA in Q1 2014 and has held it in 14 quarters since. The position peaked at $1.88M in Q2 2015. 125 funds tracked by Wall St. Rank hold ARNA as of Q4 2017.

  • Cornerstone Capital Management Holdings held 21,642 shares of Arena Pharmaceuticals Inc worth $734K as of Q4 2017.
  • Cornerstone Capital Management Holdings sold 100 Arena Pharmaceuticals Inc shares in Q4 2017, an estimated $2.85K.
  • Arena Pharmaceuticals Inc made up 0.01% of Cornerstone Capital Management Holdings's portfolio in Q4 2017, its #953 holding.
  • Cornerstone Capital Management Holdings first reported a position in Arena Pharmaceuticals Inc in Q1 2014 and has held it in 14 quarters since.
  • Cornerstone Capital Management Holdings's Arena Pharmaceuticals Inc position peaked at $1.88M in Q2 2015.
  • 125 funds tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q4 2017.

Based on Cornerstone Capital Management Holdings's 13F filing for Q4 2017, filed 14 Feb 2018.